ciprofloxacin has been researched along with quercetin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Coombs, GH; Cortázar, TM; Walker, J | 1 |
| Haritova, A; Lashev, L; Lutckanov, M; Petrov, V; Urumova, V | 1 |
| Muzyka, N; Oktyabrsky, O; Samoilova, Z; Smirnova, G | 1 |
| Abreu, AC; Borges, A; Mcbain, AJ; Saavedra, MJ; Salgado, AJ; Serra, SC; Simões, M | 1 |
| Cetin, A; Dogan, Z; Elbe, H; Taslidere, E; Turkoz, Y | 1 |
| Krukiewicz, K; Stokfisz, A; Zak, JK | 1 |
| Cetin, A; Dogan, Z; Elbe, H; Taslidere, E; Turkoz, Y; Vardi, N | 1 |
| Dey, D; Ghosh, S; Hazra, B; Ray, R | 1 |
| Abreu, AC; Saavedra, MJ; Simões, LC; Simões, M | 1 |
| Cetin, A; Demirtas, S; Dogan, Z; Elbe, H; Soysal, H; Taslidere, E | 1 |
| Cetin, A; Dogan, Z; Elibol, E; Turkoz, Y; Vardi, N | 1 |
| Ajmal, G; Bonde, GV; Khan, G; Mishra, B; Mittal, P; Pandey, VK; Singh, J; Thokala, S | 1 |
| Ajmal, G; Bakade, BV; Bonde, GV; Khan, G; Mishra, B; Mittal, P; Pandey, VK | 1 |
| Bezmaternykh, KV; Oktyabrsky, ON; Smirnova, GV; Tyulenev, AV | 1 |
| Alhajj, N; Cathcart, H; O'Reilly, NJ | 2 |
19 other study(ies) available for ciprofloxacin and quercetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine.
Topics: Animals; Anti-Infective Agents; Antiprotozoal Agents; Cell Line; Cell Nucleus; Ciprofloxacin; Ellagic Acid; Enoxacin; Flavonoids; Fluoroquinolones; Humans; Inhibitory Concentration 50; Leishmania guyanensis; Macrophages; Pentamidine; Quercetin; Topoisomerase II Inhibitors | 2007 |
Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Biological Availability; Biomarkers; Chickens; Ciprofloxacin; Dose-Response Relationship, Drug; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Quercetin; Tissue Distribution | 2011 |
Influence of plant polyphenols and medicinal plant extracts on antibiotic susceptibility of Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Galactosidase; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Herb-Drug Interactions; Kanamycin; Microbial Sensitivity Tests; Plant Extracts; Plants, Medicinal; Polyphenols; Quercetin | 2012 |
Combinatorial Activity of Flavonoids with Antibiotics Against Drug-Resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Catechin; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Erythromycin; Flavonoids; Hesperidin; Humans; Microbial Sensitivity Tests; Oxacillin; Quercetin; Rutin; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2015 |
Beneficial effects of quercetin on renal injury and oxidative stress caused by ciprofloxacin in rats: A histological and biochemical study.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Ciprofloxacin; Female; Glutathione; Kidney; Malondialdehyde; Oxidative Stress; Quercetin; Rats, Wistar; Superoxide Dismutase | 2016 |
Two approaches to the model drug immobilization into conjugated polymer matrix.
Topics: Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Microscopy, Electron, Scanning; Polymerization; Polymers; Pyrroles; Quercetin; Surface Properties | 2015 |
Quercetin protection against ciprofloxacin induced liver damage in rats.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Cytoprotection; Disease Models, Animal; Female; Oxidative Stress; Quercetin; Rats, Wistar | 2016 |
Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Caffeic Acids; Catechin; Ciprofloxacin; Drug Synergism; Ellagic Acid; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phytochemicals; Polyphenols; Quercetin; Reserpine; Tetracycline | 2016 |
Combinatorial approaches with selected phytochemicals to increase antibiotic efficacy against Staphylococcus aureus biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Synergism; Erythromycin; Flavonoids; Microbial Sensitivity Tests; Phytochemicals; Quercetin; Quinine; Staphylococcus aureus; Tetracycline | 2016 |
Effects of ciprofloxacin on fetal rat liver during pregnancy and protective effects of quercetin.
Topics: Animals; Ciprofloxacin; Female; Female Urogenital Diseases; Liver; Pregnancy; Quercetin; Rats; Rats, Inbred WF | 2017 |
Effects of ciprofloxacin and quercetin on fetal brain development: a biochemical and histopathological study.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Brain; Brain Diseases; Catalase; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Glutathione; Glutathione Peroxidase; Malondialdehyde; Oxidative Stress; Pregnancy; Quercetin; Rats, Wistar; Superoxide Dismutase | 2019 |
Ciprofloxacin HCl and quercetin functionalized electrospun nanofiber membrane: fabrication and its evaluation in full thickness wound healing.
Topics: Anti-Bacterial Agents; Antioxidants; Ciprofloxacin; Collagen; Drug Liberation; Electricity; Fibroblasts; Hydroxyproline; Materials Testing; Membranes, Artificial; Nanofibers; Oxidative Stress; Quercetin; Wound Healing | 2019 |
Biomimetic PCL-gelatin based nanofibers loaded with ciprofloxacin hydrochloride and quercetin: A potential antibacterial and anti-oxidant dressing material for accelerated healing of a full thickness wound.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Bandages; Biomimetics; Cell Line; Cell Survival; Ciprofloxacin; Drug Liberation; Female; Gelatin; Male; Mice; Nanofibers; Polyesters; Quercetin; Rats, Wistar; Staphylococcus aureus; Wound Healing | 2019 |
Effect of resveratrol and quercetin on the susceptibility of Escherichia coli to antibiotics.
Topics: Anti-Bacterial Agents; Antioxidants; beta-Galactosidase; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Kanamycin; Oxidative Stress; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Streptomycin; Stress, Physiological | 2020 |
Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
Topics: Administration, Inhalation; Aerosols; Ciprofloxacin; Dry Powder Inhalers; Particle Size; Powders; Quercetin; Water | 2022 |
Quality by design - Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation.
Topics: Administration, Inhalation; Aerosols; Ciprofloxacin; Drug Combinations; Dry Powder Inhalers; Particle Size; Powders; Quercetin; Spray Drying | 2023 |